All Stories

  1. Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome

    Article • Lupus, February 2022, SAGE Publications

    Federico Aranda

  2. A focus on the roles of histones in health and diseases

    Article • Clinical Biochemistry, August 2021, Elsevier

    Federico Aranda

  3. Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine

    Article • Lupus, August 2020, SAGE Publications

    Federico Aranda

  4. Trombofilia hereditaria y pérdidas de embarazo. Estudio de una cohorte de Argentina

    Article • Medicina Clínica, March 2018, Elsevier

    Federico Aranda

  5. Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications

    Article • Journal of Assisted Reproduction and Genetics, March 2018, Springer Science + Business Media

    Federico Aranda

  6. Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile

    Article • Lupus, February 2017, SAGE Publications

    gabriela de Larrañaga, Federico Aranda

  7. The −2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients

    Article • Clinical Rheumatology, August 2016, Springer Science + Business Media

    Federico Aranda

  8. D-Dimer as a prognostic marker of morbidity and mortality among HIV patients: a call for attention

    Article • Infectious Diseases, June 2016, Taylor & Francis

    Federico Aranda

  9. Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?: reply

    Article • Journal of Thrombosis and Haemostasis, October 2014, Elsevier

    gabriela de Larrañaga, Federico Aranda

  10. Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?

    Article • Journal of Thrombosis and Haemostasis, May 2014, Elsevier

    gabriela de Larrañaga, Federico Aranda

  11. The −308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients

    Article • International Journal of Rheumatic Diseases, March 2014, Wiley

    Federico Aranda

  12. Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs

    Article • Journal of Gastroenterology and Hepatology, January 2013, Wiley

    Federico Aranda

  13. 4G/5G plasminogen activator inhibitor-1 and −308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis

    Article • Clinical and Experimental Medicine, November 2012, Springer Science + Business Media

    Federico Aranda

  14. The distribution of allelic and genotypic frequencies of N-Acetyltransferase-2 variants in an Argentine population

    Article • The Journal of Infection in Developing Countries, September 2012, Journal of Infection in Developing Countries

    Federico Aranda

  15. The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study

    Article • European Cytokine Network, March 2012, John Libbey Eurotext

    Federico Aranda